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معادلة لوغارمتية لوصف العالقة بني زيادة احلساسية اإلشعاعية عند اجلرع 
املنخفضة والبقاء عند 2 غراي
 فائقة عبد الكرمي عزوز و �شوزان خالد ها�شم
امللخ�ص: الهدف: تتاأثر احل�شا�شية ال�شعاعية داخلية املن�شاأ امل�شتخدمة عند اجلرع املعتمدة يف العالج الإ�شعاعي بفرط احل�شا�شية الإ�شعاعية 
و زيادة املقاومة الإ�شعاعية )HRS/IRR(عند اجلرع املنخف�شة. يهدف هذا العمل اىل ا�شتك�شاف هذه العالقة. الطريقة: مت حتليل منحنيات 
البقاء لثمانية ع�رش خط خلوي من خاليا الأورام الب�رشية و ذلك با�شتخدام منوذجني لعملية املالءمة للنقاط العملية من اأجل احل�شول على 
املوؤ�رشات ال�رشورية ذات العالقة بهذه الدرا�شة. النتائج: ميكن و�شف ن�شبة زيادة املقاومة ال�شعاعية αs/αr مقابل البقاء عند 2 غراي 
بعالقة لوغارمتية توؤدي اإىل �شل�شة من امل�شتقيمات. اخلال�صة: العالقة امل�شتخل�شة تبني وجود عالقة مبا�رشة بني فرط التح�ش�س- زيادة 
املقاومة الإ�شعاعية والبقاء عند اجلرع املعتمدة �رشيريا وهي 2 غراي.
مفتاح الكلمات: فرط التح�ش�س، العالج بالأ�شعة، خط خلوي، ورم، حتليل.
abstract: Objectives: Intrinsic radiosensitivity at doses used in radiotherapy is linked to hypersensitivity (HRS) 
and increased radio resistance (IRR) at low doses. The aim of this study was to explore this relationship. Methods: 
Survival curves for 18 human tumour cell lines were analysed, using two models to fit the data points in order to 
extract the necessary parameters relevant for this study. Results: The IRR ratio αs/αr versus the survival at 2 gray 
(Gy) can be described by a logarithmic relation which leads to a series of straight lines. Conclusion: The relationship 
obtained implies that there is a direct link between HRS/IRR and survival at clinically relevant doses of 2 Gy.
Keywords: Hypersensitivity, radiotherapy; Cell Line; Tumor; Analysis.
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Advances in Knowledge
- For the first time, the relationship between the increased radio resistance (IRR) αs/αr and the survival at 2 gray (Gy) (SF2) has been 
described by a series of straight lines.
- This study uses the repairable-conditionally repairable (RCR) model for the first time to extract αs in addition to the inducible repair (IR) 
model, which is usually applied for this purpose.
- Since the RCR model is statistical in nature, special analysis had to be done in order to extract the hypersensitivity (HRS) parameters αs.
- To have good fits, the survival curve data points were separated into two parts. The hypersensitivity region part (<1 Gy) was fitted to the 
IR or the RCR model, and the conventional survival curve region (>1Gy with the 0 Gy point) was fitted to the linear quadratic model.
Application to Patient Care
- The influence of HRS/IRR on clinically relevant doses is of great importance in radiation therapy. 
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Over the last two decades, much attention has been focused on the existence of a hypersensitivity region 
in the survival curves for many mammalian cells 
at doses below 0.5 gray (Gy). This makes the 
linear-quadratic (LQ) equation inappropriate 
for use at low doses. This phenomenon, termed 
hypersensitivity (HRS), precedes the occurrence 
of relative resistance per unit dose to cell killing by 
radiation over the dose range ~0.5–1 Gy. This latter 
phenomenon is increased radioresistance (IRR). 
The ratio of the initial slope of the survival curve 
associated with the hypersensitivity region (αs) 
to the slope in the shoulder region (αr) is usually 
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used as a metric in the analysis of the HRS/IRR 
phenomenon. The HRS/IRR phenomenon has been 
found in different types of cell lines, both in vivo 
and in vitro. The former includes cell lines from 
plants, bacteria and mammals. The latter mostly 
involve human tumour cell lines.1–5
Many researchers have tried to explain this 
phenomenon depending on the analysis of cell 
phase or gene structure, while others have tried 
to study the influence of this phenomenon on 
dose fractionation in radiotherapy by analysing 
survival curve parameters.1,6,8,10–14 Explanations of 
this phenomenon are still regarded as matters of 
controversy.
The use of mathematical equations to extract 
useful parameters to be applied in radiotherapy 
procedures is very important. In the case of HRS/
IRR curves, there is always a need to establish 
a relation between αs/αr and the survival at 2 Gy 
(SF2), which is clinically relevant. Those attempting 
to develop a standard equation to be used in such 
a procedure have been faced with difficulties 
related to an inadequate or poorly fitting equation, 
colony assays being unreliable at low doses, and 
the difference in the new technology methods 
that are used to identify the position of the plated 
cells such as the fluorescence-activated cell sorting 
method (FACS) and the dynamic microscope image 
processing scanner method (DMIPS).12
In order to make it possible to fit the 
hypersensitivity survival curves to a model and 
extract useful parameters for the analysis, the LQ 
model was modified by Joiner and Johns.15
This new model, the inducible repair (IR) model, 
involves two new parameters in addition to α and 
β in the original LQ model. These parameters 
are αs which is a measure of the initial slope 
in the low dose region and the Dc parameter 
which represents the dose at which the inflexion 
occurs from HRS to IRR. The α parameter in the 
LQ model, termed αr in this model, defines the 
slope in the shoulder region. The most common 
inducible repair (IR) model equation is given by: 
 
S = exp (– αr 1 + (α / αr -) e  –D/Dc) D – βD2)  
[Equation 1]
where S is the survival fraction, D is the dose and αs, 
αr and Dc as defined above.
12 Equation 1 has been 
used extensively to fit the HRS/IRR curves, with 
varying goodness of fit results. Another equation 
based on statistical analysis has been put forward to 
describe HRS/IRR data. This equation does not give 
αs and αr directly. Consequently, it is not used as 
commonly in αs/αr analysis. The model that adopts 
this equation is called the repairable-conditionally 
repairable (RCR) model and is described by: 
S(D) = e – aD + bDe – cD  [Equation 2]16 
 
To overcome some of the obstacles that prevent 
obtaining reliable values for αs/αr and for SF2 to be 
used in establishing the relationship between them, 
we have chosen to fit a set of survival curves that 
belong to human tumour cell lines to Equations 
1 and 2 in order to obtain smooth curves that 
reasonably describe all survival data with the aim of 
finding a relation between αs/αr and SF2.
Methods
A set of 18 survival curves related to various kinds 
of human tumour cell lines were compiled from the 
literature.7,17–25 Data points and their error bars were 
obtained using programming techniques described 
in previous work.26 Each survival data set for a 
given cell line were fitted to the IR model and the 
RCR model using all data points on the curve. The 
fit results did not prove to be satisfactory in most 
cases. This was particularly evident in the case of the 
IR model. However, fits carried out using the HRS/
IRR part of the survival curve produced acceptable 
results. This part is represented by the region of 0–1 
Gy or slightly higher in very few cases. The other 
part of the survival curve (>1 Gy) together with 
the 0 Gy dose represents the conventional survival 
curve with no HRS/IRR region. This was fitted to 
the LQ equation. The criteria used for considering 
the fit acceptable involved having the fitted curve as 
close as possible to data points with small residuals 
values. In addition, the residuals distribution should 
be of the random type narrowly centred near zero. 
The fulfillment of these criteria was checked by 
having the sum of squares error (SSE) and the root 
mean square error (RMSE) being close to zero, and 
R2 and the adjusted R2 (AJR) are very close to 1.
A problem arises when handling cases with 
survival curves data points which are randomly 
distributed. These cannot be described by a 
smooth curve. Such cases are usually associated 
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with small fractional doses arising from the 
difficulty in measuring small changes in survival. 
In these cases, the curve-fitting procedure becomes 
fruitless. In order to overcome this problem, some 
data treatment becomes necessary. The treatment 
employed involves constrained data smoothing. 
This is performed using the MATLAB library 
routine “smooth”, which uses a successive averaging 
method. In addition, one constraint was added on 
the smoothing process. The constraint was that 
no smoothed data point was to move during the 
smoothing process beyond its error-bar boundaries. 
This process was similar to weighting the data 
points, but it was found that the smoothing method 
gave better results. 
The other problem was that the RCR model 
is statistical in nature; thus, it does not give the 
required physical parameters directly as is the case 
with the the IR model. This problem was solved by 
finding the first derivative on the survival curve at 
the initial slope which represents αs, and the first 
minimum value of the survival followed by increase 
of survival defined as Dc. The α parameter from the 
LQ fit was used as αr. Whether one is using either 
the IR model or the RCR model, this treatment 
is considered justified since the IR model is not 
efficient enough to control the HRS/IRR region and 
the conventional part of the survival curve at the 
same time. The same argument applies in the case 
of the RCR model, which is better at describing the 
data than the former in spite of its statistical nature.
Results 
The fitting results from the models IR, RCR, and 
LQ for various cell lines are shown in Table 1. The 
first column in Table 1 gives the cell lines. Columns 
2, 3 and 4 represent the αs, αr and Dc parameters 
that were obtained by selecting the best fits to the 
region 0–1 Gy when using the IR model. Columns 
5 and 6 represent the αs and Dc parameters that 
were derived from the best fits to the RCR model 
Table 1: Best fits parameters from inducible repair, repairable-conditionally repairable and linear-quadratic models 
Cell lines Parameters obtained from best fits to the 
IR model
Derived parameters from 
best fits to the RCR model
Parameters obtained from 
best fits to the LQ model
αr (Gy
-1) αs (Gy
-1) Dc (Gy) αs (Gy
-1) Dc (Gy)
α (Gy-1) SF2 derived
RT112 (18) 0.27 ± 0.00 1.07 ±0.21 0.29 ± 0.06 0.99 0.47 0.17 ± 0.50 0.62
AGS (19) 0.24 ± 0.00 1.30 ± 0.19 0.39 ± 0.07 1.19 0.5 0.42 ± 0.05 0.45
PC3 (19) 0.77 ± 0.00 0.68 ± 0.17 0.44 ± 0.12 0.66 0.51 0.27 ±0.07 0.52
T98G (20) 0.39 ±0.00 0.84 ±0.34 0.45 ± 0.29 0.74 0.56 0.15 ± 0.02 0.69
Be11 (7) 0.16 ± 0.00 1.37 ± 0.19 0.25 ± 0.04 1.294 0.39 0.16 ± 0.03 0.68
A549 (19) 0.82 ± 0.00 1.26 ± 1.32 0.16 ± 0.12 1.02 0.32 0.20 ± 0.06 0.71
BMG1 (21) 5 19.55 ± 7.36 0.08 ± 0.02 14.27 0.09 0.10 ± 0.10 0.81
DU145 (22) 0.38 ± 0.00 0.54 ± 0.19 0.32 ± 0.12 0.49 0.4 0.17 ± 0.01 0.64
T98G (17) 0.29 ± 0.00 1.28 ± 0.62 0.13 ± 0.04 0.89 0.18 0.08± 0.03 0.73
HT-29 (23) 0.21 ±0.00 0.98 ± 0.11 0.23 ± 0.02 0.88 0.28 0.07 ± 0.01 0.71
MeWo (23) 0.38 ± 0.00 1.00 ± 0.97 0.46 ± 0.68 0.83 0.63 0.25 ± 0.02 0.27
PECA4197 
(21)
0.29 ± 0.00 4.61 ± 0.87 0.35 ± 0.06 4.16 0.32 0.12 ± 0.00 0.64
PECA4451 
(21)
0.30 ± 0.00 2.93 ± 0.09 0.37 ± 0.12 2.63 0.38 0.40± 0.0624 0.65
BJ (24) 0.31 ± 0.00 1.28 ± 0.73 0.85 ± 0.50 1.18 1.1 0.28 ± 0.09 0.57
SCC-61 (25) 0.1 ± 0.00 1.41 ± 0.61 0.8 fixed 0.87 0.8 0.47 ± 0.09 0.30
SQ20B (25) 0.5 fixed 0.69 ± 0.21 0.63 ± 0.17 0.51 0.65 0.03 ± 0.01 0.88
U1 (22) 0.70 ± 0.00 0.18 ± 0.04 0.11 ± 0.02 0.061 0.32 0.001 ± 0.011 0.92
U87 (21) 0.20 ± 0.00 10.35 ± 3.06 0.22 ± 0.05 9.211 0.19 0.70 ± 0.40 0.57
IR = inducible repair; RCR = repairable-conditionally repairable; LQ = linear-quadratic; Gy = gray.
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in the region of 0–1 Gy using the first derivative 
method mentioned above to obtain αs and the first 
minimum point on the curve to get Dc. The last two 
columns in this table represent the αr and the SF2 
values that were obtained from fitting the survival 
curve data in the region >1 Gy together with the 0 
Gy to the LQ model. Figure 1 shows an example of 
the fit for the three models for the cell line RT112. 
When αs/αr against SF2 are plotted on a linear 
scale, the data points are distributed randomly. 
However, when the αs/αr for the best fit results 
from the RCR model and the LQ model are plotted 
on a logarithmic scale against SF2, the data points 
become grouped in three straight lines intersecting 
at one point. Good straight line fits for all three lines 
are obtained by fitting the data to the equation:
Log (y) = aX + b   [Equation 3]
The results of such fits are shown in Figure 2A 
with the dashed blue line representing the cells 
AGS, U87, PECA4197, BMGI; the solid red line 
representing the cells PC3, BJ, RT112, PECA4451, 
HT-29, U1, GT98, Be11, and the dotted green line 
representing the cells DU145, T98G, A549, SQ20B. 
Only two cell lines did not fit to any of these lines. 
These are the MeWo and SCC61 data. One possible 
explanation is that they could perhaps belong to 
other lines. Furthermore, the survival data points 
for T98G were taken from two experiments and 
there seems to be significant differences between 
the two.17,20 One group fitted well with the solid red 
line while the other group fitted well to the dotted 
green line.17,20
Figure 1. Survival curve fits for RT112 cell line to the LQ, IR, and RCR models.18 The upper right figure is a magnified 
portion for IR and RCR fits in the hypersensitivity region.
LQ = linear-quadratic; RCR = repairable-conditionally repairable; IR = inducible repair; Gy = gray.
Figure 2 A & B. Fitted lines to Equation 3. A: using αs from best fits to the repairable-conditionally repairable (RCR) 
model and αr from best fits to the linear-quadratic (LQ) model, and B: using αs derived from fitting smoothed and 
non-smoothed data to the RCR model and αr from fitting smoothed and non-smoothed data to the LQ model. 
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In order to exclude the possibility that the data 
points were not biased by the smoothing process, 
we plotted the combined data values of αs/αr 
from both the RCR model and the LQ model. In 
this case, a set of 4 values of αs/αr for each SF2 
value was obtained. These were αs smoothed/αr 
smoothed, αs non-smoothed/αr non-smoothed, αs 
smoothed/αrnon-smoothed and αs non-smoothed/
αr smoothed. Similar results were obtained, as seen 
in Figure 2B. The procedure was repeated for the 
case of the IR model (i.e. αs was taken from the IR 
model fits and αr values were taken from the LQ 
model fits). The results that correspond to Figures 
2A and B in the RCR model are shown as Figures 3A 
and B for the IR model case. The three straight lines 
obtained were also fitted to Equation 3. The results 
of fits indicate that the values of the parameters a 
and b in the case of the IR model are slightly higher 
than those in the case of the RCR model.
The final cross-check employed involved plotting 
all the data points from both models (8 values of αs/
αr for each SF2 value). Self-consistent results were 
obtained as shown in Figure 4. The fitted a and b 
parameters obtained by fitting Equation 3 to the 
lines shown in Figures 2–4 are shown in Table 2, 
with columns 2 and 3 represent the dashed blue 
line (Line 1) parameters, columns 4 and 5 represent 
the solid red line (Line 2) parameters and columns 
6 and 7 represent the dotted green line (Line 3) 
parameters.
Discussion
As seen from Table 2, all fits gave very close results 
for the a and b parameters. This was independent of 
whether the αs was taken from the IR model fits or 
the RCR model fits, or when the αs from the IR and 
the RCR fits were amalgamated. In all cases, the a 
Figure 3 A & B. Fitted lines to Equation 3. A: using αs from best fits to the inducible repair (IR) model and αr from 
best fits to the linear-quadratic (LQ) model, and B: using αs derived from fitting smoothed and non-smoothed data 
to the IR model and αr from fitting smoothed and non-smoothed data to the LQ model. 
Table 2: The a and b parameters obtained from fitting lines 1–3 to the equation ± standard deviation
Data type Fitting parameters for 
Line 1
Fitting parameters for 
Line 2
Fitting parameters for 
Line 3
a b a b a b
αs from best RCR fit/αr from best LQ fit 4.30 ± 0.85 -1.32 ± 0.53 3.20 ± 0.25 -1.26 ± 0.17 2.85 ± 0.62 -1.33 ± 0.45
αs from all RCR fit/αr from all LQ fit 4.60 ± 0.19 -1.52 ± 0.12 3.53 ± 0.21 -1.47 ± 0.14 3.15 ± 0.26 -1.53 ± 0.19
αs from best IR fit /αr from best LQ fit 4.76 ± 0.64 -1.55 ± 0.40 4.09 ± 0.39 -1.74 ± 0.26 3.04 ± 0.69 -1.37 ± 0.51
αs from all IR fit/αr from all LQ fit 4.99 ± 0.36 -1.77 ± 0.23 4.06 ± 0.31 -1.75 ± 0.20 3.02 ± 0.32 -1.35 ± 0.23
αs from all data fit/αr from all LQ fit 4.73 ± 0.23 -1.58 ± 0.15 3.81 ± 0.18 -1.60 ± 0.12 2.97 ± 0.36 -1.35 ± 0.26
RCR = repairable-conditionally repairable; LQ = linear-quadratic; IR = inducible repair.
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and b values obtained proved to be consistent. The 
results confirmed the log-linear relation between 
αs/αr and SF2. This represents a diversion from 
the method suggested by Dasu and Kamp which 
involved plotting αs/αr on a linear scale.
12 In their 
work, an attempt to find a linear relation resulted 
in inadequate fits. It may be worth mentioning, 
however, that their work involved the use of data 
for different cell lines while only human tumour cell 
lines were used in the present work. Furthermore, 
the procedure used by Dasu and Kamp depended 
on the IR model which fits the HRS/IRR part of the 
survival curve only but fails to fit the conventional 
part (>1Gy) in a one-fit process. 
The present work involved fitting each part 
separately, helping to give more precise values for 
the fit parameters. Also, Joiner et al. used published 
data to find a relation between αs/αr and SF2.
1 Their 
results showed some kind of logarithmic linear 
relationship but no fitting was provided. This may 
be due to the interference between the human 
tumour cell lines and other cell lines which makes 
the picture less clear.
It may thus be argued that the use of logarithmic 
procedure can be important in radiotherapy. This 
is due to the fact that the intrinsic radiosensitivity 
at clinically relevant doses is directly linked to the 
cell’s ability to mount an adaptive response as a 
result of exposure to very low doses of radiation. 
The survival at 2 Gy doses, which is usually used in 
dose fractionation, is believed to be affected by the 
HRS/IRR phenomenon. It may cause the tumour 
to grow again. So, a revision of dose fractionation 
is required with the need to study each cell line 
separately. 
Conclusion
Precisely fitting parameters that describe the HRS 
at low doses of radiation αs and the survival in the 
shoulder region αr are obtained by dividing the 
survival curve data points into two groups. The 
first group (<1 Gy) fits well to the IR and the RCR 
models. The second group (>1 Gy plus 0 Gy point) 
fits well to the LQ model. The αs/αr ratio plotted on 
a logarithmic scale against the survival at 2 Gy as 
a linear scale displays a series of straight lines. The 
lines are well-fitted to a logarithmic-linear relation 
with two parameters a and b with good quality fits. 
The relations obtained imply that there is a direct 
link between the HRS/IRR ratio and the survival at 
the clinically relevant dose of 2 Gy. 
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